...
首页> 外文期刊>Endocrinology >Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: Role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis
【24h】

Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: Role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis

机译:血红素疗法可改善雄性链脲佐菌素诱发的糖尿病大鼠的肾脏功能:血红素加氧酶/心钠素/脂联素轴的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Diabetic nephropathy is characterized by elevated macrophage infiltration and inflammation. Although heme-oxygenase (HO) is cytoprotective, its role in macrophage infiltration and nephropathy in type 1 diabetes is not completely elucidated. Administering the HO inducer, hemin, to streptozotocin-diabetic rats suppressed renal proinflammatory macrophage-M1 phenotype alongside several proinflammatory agents, chemokines, and cytokines including macrophage inflammatory protein 1α (MIP-1α), macrophage-chemoattractant protein-1 (MCP-1), TNF-α, IL-1β, IL-6, nuclear factor-kB (NF-kB), and aldosterone, a stimulator of the inflammatory/oxidative transcription factor, NF-kB. Similarly, hemin therapy attenuated extracellular matrix/profibrotic proteins implicated in renal injury including fibronectin, collagen-IV, and TGF-1 and reduced several renal histopathological lesions such as glomerulosclerosis, tubular necrosis, tubular vacuolization, and interstitial macrophage infiltration. Furthermore, hemin reduced markers of kidney dysfunction like proteinuria and albuminuria but increased creatinine clearance, suggesting improved kidney function. Correspondingly, hemin significantly enhanced the antiinflammatory macrophage-M2 phenotype, IL-10, adiponectin, HO-1, HO activity, and atrial natriuretic-peptide (ANP), a substance that abates TNF-α, IL-6, and IL-1β, with parallel increase of urinary cGMP, a surrogate marker of ANP. Contrarily, coadministering the HO inhibitor, chromium-mesoporphyrin with the HO-inducer, hemin nullified the antidiabetic and renoprotective effects, whereas administering chromium-mesoporphyrin alone abrogated basal HO activity, reduced basal adiponectin and ANP levels, aggravated hyperglycemia, and further increased MCP-1, MIP-1α, aldosterone, NF-kB, TNF-α, IL-6, IL-1β, proteinuria/albuminuria, and aggravated creatinine clearance, thus exacerbating renal dysfunction, suggesting the importance of the basal HO-Adiponectin-ANP axis in renoprotection and kidney function. Collectively, these data suggest that hemin ameliorates diabetic nephropathy by selectively enhancing the antiinflammatory macrophage-M2 phenotype and IL-10 while concomitantly abating the proinflammatory macrophage-M1 phenotype and suppressing extracellular matrix/profibrotic factors with reduction of renal lesions including interstitial macrophage infiltration. Because aldosterone stimulate NF-kB, which activates cytokines like TNF-α, IL-6, IL-1β that in turn stimulate chemokines such asMCP-1andMIP-1α topromotemacrophage-M1 infiltration, the hemin-dependent potentiation of the HO-Adiponectin-ANP axis may account for reduced macrophage infiltration and inflammatory insults in streptozotocin-diabetic rats.
机译:糖尿病性肾病的特征在于巨噬细胞浸润和炎症增加。尽管血红素加氧酶(HO)具有细胞保护作用,但尚未完全阐明其在1型糖尿病中巨噬细胞浸润和肾病中的作用。对链脲佐菌素-糖尿病大鼠给予HO诱导剂血红素可抑制肾促炎性巨噬细胞M1表型以及几种促炎剂,趋化因子和细胞因子,包括巨噬细胞炎性蛋白1α(MIP-1α),巨噬细胞趋化蛋白1(MCP-1) ,TNF-α,IL-1β,IL-6,核因子-kB(NF-kB)和醛固酮(炎性/氧化性转录因子NF-kB的刺激物)。类似地,血红素疗法减弱了与肾脏损伤有关的细胞外基质/纤维化蛋白,包括纤连蛋白,胶原蛋白IV和TGF-1,并减少了几种肾脏组织病理学损害,例如肾小球硬化,肾小管坏死,肾小管空泡化和间质巨噬细胞浸润。此外,血红素减少了肾功能不全的标志物,如蛋白尿和蛋白尿,但肌酐清除率增加,提示肾功能改善。相应地,血红素显着增强了抗炎巨噬细胞-M2表型,IL-10,脂联素,HO-1,HO活性和心房利钠肽(ANP)(一种可减轻TNF-α,IL-6和IL-1β的物质)。 ,同时尿cGMP升高,这是ANP的替代指标。相反,将HO抑制剂铬-中卟啉与HO-诱导剂共同使用会取消抗糖尿病和肾保护作用,而单独施用铬-中卟啉会废除基础HO活性,降低基础脂联素和ANP水平,加重高血糖,并进一步增加MCP- 1,MIP-1α,醛固酮,NF-kB,TNF-α,IL-6,IL-1β,蛋白尿/白蛋白尿,并增加了肌酐清除率,因此加重了肾功能不全,提示基础HO-脂联素-ANP轴的重要性在肾脏保护和肾脏功能。总体而言,这些数据表明,血红素通过选择性增强抗炎巨噬细胞-M2表型和IL-10来改善糖尿病性肾病,同时减少促炎巨噬细胞-M1表型并抑制细胞外基质/纤维化因子,从而减少包括间质巨噬细胞浸润在内的肾脏损害。由于醛固酮会刺激NF-kB,从而激活TNF-α,IL-6,IL-1β等细胞因子,进而刺激趋化因子(如MCP-1和MIP-1α)向促性巨噬细胞-M1渗透,因此HO-脂联素-ANP的血红素依赖性增强轴可能解释了链脲佐菌素-糖尿病大鼠中巨噬细胞浸润和炎症损伤的减少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号